Endoplasmic reticulum protein 29 regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells

Oncogene

Volumn 32, Issue 10, 2013, Pages 1240-1251

  Bambang, I F ^a   Lee, Y K ^a   Richardson, D R ^b   Zhang, D ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

cell polarity; epithelial morphogenesis; ERp29; mesenchymal epithelial transition; tight junctions

Indexed keywords

ACTIN; CELL PROTEIN; CYTOKERATIN 19; ENDOPLASMIC RETICULUM PROTEIN 29; PROTEIN ZO1; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL CONTACT; CELL POLARITY; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS FIBER; UPREGULATION;

BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEAT-SHOCK PROTEINS; HUMANS; MCF-7 CELLS; MICROSCOPY, CONFOCAL; PHENOTYPE; TRANSFECTION; UP-REGULATION;

EID: 84874786165     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.149     Document Type: Article

References (65)

1. Garrod D, Chidgey M, North A. Desmosomes: differentiation, development, dynamics and disease. Curr Opin Cell Biol 1996; 8: 670-678.
2. Imhof BA, Vollmers HP, Goodman SL, Birchmeier W. Cell-cell interaction and polarity of epithelial cells: specific perturbation using a monoclonal antibody. Cell 1983; 35: 667-675.
3. Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 2009; 15: 7135-7139.
4. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
5. Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001; 13: 555-562.
6. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005; 132: 3151-3161.
7. Chaffer CL, Dopheide B, McCulloch DR, Lee AB, Moseley JM, Thompson EW et al. Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis 2005; 22: 115-125.
8. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362-374.
9. Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5'CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275: 2727-2732.
10. De Craene B, van Roy F, Berx G. Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal 2005; 17: 535-547.
11. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-558.
12. Thiery JP, Sleeman J. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142.
13. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007; 26: 6979-6988.
14. Cano A, Pé rez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG et al. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83.
15. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E et al. The two-handed E box binding zinc Wnger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7: 1267-1278.
16. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M et al. dEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005; 24: 2375-2385.
17. Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S et al. E-cadherin induces mesenchymal-To-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA 1999; 96: 6249-6254.
18. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22: 894-907.
19. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 333-339.
20. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002; 21: 3241-3246.
21. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-939.
22. Coradini D, Casarsa C, Oriana S. Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment. Acta Pharmacol Sin 2011; 32: 552-564.
23. Cereijido M, Valdes J, Shoshani L, Contreras RG. Role of tight junctions in establishing and maintaining cell polarity. Annu Rev Physiol 1998; 60: 161-177.
24. Tanos B, Rodriguez-Boulan E. The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene 2008; 27: 6939-6957.
25. Gibson MC, Perrimon N. Apicobasal polarization: epithelial form and function. Curr Opin Cell Biol 2003; 15: 747-752.
26. Shin K, Fogg VC, Margolis B. Tight junctions and cell polarity. Annu Rev Cell Dev Biol 2006; 22: 207-235.
27. Latorre IJ, Roh MH, Frese KK, Weiss RS, Margolis B, Javier RT. Viral oncoproteininduced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J Cell Sci 2005; 118: 4283-4293.
28. Baryshev M, Sargsyan E, Mkrtchian S. ERp29 is an essential endoplasmic reticulum factor regulating secretion of thyroglobulin. Biochem Biophys Res Commun 2006; 340: 617-624.
29. Shnyder SD, Mangum JE, Hubbard MJ. Triplex profiling of functionally distinct chaperones (ERp29/PDI/BiP) reveals marked heterogeneity of the endoplasmic reticulum proteome in cancer. J Proteome Res 2008; 7: 3364-3372.
30. Bambang IF, Xu S, Zhou J, Salto-Tellez M, Sethi SK, Zhang D. Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells. Lab Invest 2009; 89: 1229-1242.
31. Farmaki E, Mkrtchian S, Papazian I, Papavassiliou AG, Kiaris H. ERp29 regulates response to doxorubicin by a PERK-mediated mechanism. Biochim Biophys Acta 2011; 1813: 1165-1171.
32. Zhang D, Putti TC. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells. Exp Cell Res 2010; 316: 3522-3531.
33. Qi L, Wu P, Zhang X, Qiu Y, Jiang W, Huang D et al. Inhibiting ERp29 expression enhances radiosensitivity in human nasopharyngeal carcinoma cell lines. Med Oncol 2012; 29: 721-728.
34. Gao D, Bambang IF, Putti TC, Lee YK, Richardson DR, Zhang D. ERp29 induces breast cancer cell growth arrest and survival via modulation ofactivation of p38 and up-regulation of ER stress protein p58IPK. Lab Invest 2012; 92: 200-213.
35. Das S, Smith TD, Sarma JD, Ritzenthaler JD, Maza J, Kaplan BE et al. ERp29 restricts Connexin43 oligomerization in the endoplasmic reticulum. Mol Biol Cell 2009; 20: 2593-2604.
36. Lacroix M, Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004; 83: 249-289.
37. Ross DT, Perou CM. A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers 2001; 17: 99-109.
38. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997; 137: 481-492.
39. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 2008; 68: 6241-6250.
40. Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 2008; 1778: 660-669.
41. Chen YT, Stewart DB, Nelson WJ. Coupling assembly of the E-cadherin/ beta-catenin complex to efficient endoplasmic reticulum exit and basal-lateral membrane targeting of E-cadherin in polarized MDCK cells. J Cell Biol 1999; 144: 687-699.
42. Joberty G, Petersen C, Gao L, Macara IG. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol 2000; 2: 531-539.
43. Lin D, Edwards AS, Fawcett JP, Mbamalu G, Scott JD, Pawson T. A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signalling and cell polarity. Nat Cell Biol 2000; 2: 540-547.
44. Ohno S. Intercellular junctions and cellular polarity: the PAR-aPKC complex, a conserved core cassette playing fundamental roles in cell polarity. Curr Opin Cell Biol 2001; 13: 641-648.
45. Katoh K, Kano Y, Amano M, Kaibuchi K, Fujiwara K. Stress fiber organization regulated by MLCK and Rho-kinase in cultured human fibroblasts. Am J Physiol Cell Physiol 2001; 280: C1669-C1679.
46. Watanabe T, Hosoya H, Yonemura S. Regulation of myosin II dynamics by phosphorylation and dephosphorylation of its light chain in epithelial cells. Mol Biol Cell 2007; 18: 605-616.
47. Ren XD, Wang R, Li Q, Kahek LA, Kaibuchi K, Clark RA. Disruption of Rho signal transduction upon cell detachment. J Cell Sci 2004; 117: 3511-3518.
48. Somlyo AP, Somlyo AV. Ca2 sensitivity of smooth muscle and nonmuscle myosin II modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003; 83: 1325-1358.
49. Sells MA, Boyd JT, Chernoff J. p21-Activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts. J Cell Biol 1999; 145: 837-849.
50. Sanders LC, Matsumura F, Bokoch GM, de Lanerolle P. Inhibition of myosin light chain kinase by p21-activated kinase. Science 1999; 283: 2083-2085.
51. Hunter MP, Zegers MM. Pak1 regulates branching morphogenesis in 3D MDCK cell culture by a PIX and b1-integrin-dependent mechanism. Am J Physiol Cell Physiol 2010; 299: C21-C32.
52. Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 2007; 127: 2525-2532.
53. Perez-Moreno M, Jamora C, Fuchs E. Sticky business: orchestrating cellular signals at adherens junctions. Cell 2003; 112: 535-548.
54. Swisshelm K, Macek R, Kubbies M. Role of claudins in tumorigenesis. Adv Drug Deliv Rev 2005; 57: 919-928.
55. Hoover KB, Liao SY, Bryant PJ. Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 1998; 153: 1767-1773.
56. Martin TA, Watkins G, Mansel RE, Jiang WG. Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer 2004; 40: 2717-2725.
57. Baas AF, Kuipers J, van der Wel NN, Batlle E, Koerten HK, Peters PJ et al. Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 2004; 116: 457-466.
58. Bilder D, Schober M, Perrimon N. Integrated activity of PDZ proteincomplexes regulates epithelial polarity. Nat Cell Biol 2003; 5: 53-58.
59. Huang L, Muthuswamy SK. Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators. Curr Opin Genet Dev 2010; 20: 41-50.
60. Royer C, Lu X. Epithelial cell polarity: a major gatekeeper against cancer? Cell Death Differ 2011; 18: 1470-1477.
61. Gardiol D, Zacchi A, Petrera F, Stanta G, Banks L. Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression. Int J Cancer 2006; 119: 1285-1290.
62. Zen K, Yasui K, Gen Y, Dohi O, Wakabayashi N, Mitsufuji S et al. Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma. Oncogene 2009; 28: 2910-2918.
63. Rothenberg SM, Mohapatra G, Rivera MN, Winokur D, Greninger P, Nitta M et al. A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. Cancer Res 2010; 70: 2158-2164.
64. Simons K, Wandinger-Ness A. Polarized sorting in epithelia. Cell 1990; 62: 207-210.
65. Rodriguez-Boulan E, Powell SK. Polarity of epithelial and neuronal cells. Annu Rev Cell Biol 1992; 8: 395-427.